GlassScriptPhysician profile
Shawn A Tassone
NPI 1518940808
$1,279,015.41
in general payments reported to CMS, 2019-2025
15 companies · $8,587 in 2025
The $8,587 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189K · 2020: $144K · 2021: $434K · 2022: $268K · 2023: $198K · 2024: $37K · 2025: $8,587.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $221K · Travel and Lodging: $20K · Food and Beverage: $2,805.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $221,100.00 |
| Travel and Lodging | $19,584.70 |
| Food and Beverage | $2,805.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acessa Health INC. | $1,162,260.03 | 2019-2025 | Acessa Provu System |
| Intuitive Surgical, INC. | $103,794.52 | 2019-2022 | |
| Hologic Sales and Service, LLC | $10,762.31 | 2019-2024 | Acessa Provu System, Coolseal Generator |
| Cytyc Surgical Products, LLC | $1,405.62 | 2025 | Acessa Provu System |
| Mimedx Group, INC. | $408.75 | 2024 | |
| Sumitomo Pharma America, INC. | $137.62 | 2023-2024 | Myfembree, Gemtesa |
| Avanos Medical | $52.68 | 2020-2021 | |
| Coopersurgical, INC. | $44.88 | 2020 | |
| Abbvie INC. | $44.18 | 2019 | |
| Evofem Biosciences, INC. | $21.60 | 2021 | |
| Covidien LP | $21.60 | 2019 | |
| Ibsa Pharma INC. | $18.73 | 2022 | |
| Astellas Pharma US INC | $16.87 | 2023 | Veozah |
| Myovant Sciences INC. | $13.29 | 2022 | |
| Dysis Medical, INC. | $12.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Tassone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.